medicalxpress - Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol.
AI Summary: Researchers are testing gene‑editing approaches aimed at providing a single‑procedure solution for elevated LDL cholesterol. Early human studies probe safety and durability, but experts urge patients to continue proven lipid‑lowering therapies for now. The line between ambitious science and everyday clinical care remains prudently guarded.
Therapeutic HPV vaccine slows throat tumors in preclinical tests / 3 months
Bayer’s Asundexian Reduces Stroke Risk by 26% in Phase 3 Trial / 3 months
Eikon Therapeutics raises $381M IPO for cancer drug advancement / 3 months
Aktis Oncology IPO boosts radiopharmaceutical pipeline / 4 months
Tumor bacteria drive head and neck immunotherapy resistance / 4 months
Giredestrant lowers recurrence risk in early-stage breast cancer / 5 months
Protego Bio Secures $130M for AL Amyloidosis Therapy Development / 5 months
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.